CIK 0001374339 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
ProMIS Neurosciences Inc.
Sign in to watch- Ticker
- PMN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Canada (Federal Level)
- Entity type
- operating
- Phone
- 416-847-6898
- Business address
- SUITE 200, 1920 YONGE STREET, TORONTO, Ontario, Canada, M4S 3E2
- Former names
- AMORFIX LIFE SCIENCES LTD
- Open-market buys, last 90 days
- $134,746
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$134,746. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-02 | Cashman Neil Chief Scientific Officer | Purchase | +10,000 | $3.86 | $39K | 14,532 |
| 2026-05-20 | Cashman Neil Chief Scientific Officer | Grant or award · Option (right to buy) | +50,000 | 50,000 | ||
| 2026-02-03 | Cashman Neil Chief Scientific Officer | Grant or award | +4,122 | $12.13 | $50K | 4,122 |
| 2026-02-03 | Cashman Neil Chief Scientific Officer | Grant or award · Warrants to purchase Common Shares | +4,122 | 4,122 | ||
| 2025-09-22 | Cashman Neil Chief Scientific Officer | Grant or award · Option (right to buy) | +165,000 | 165,000 | ||
| 2025-02-10 | Cashman Neil Chief Scientific Officer | Purchase | +15,000 | $0.97 | $15K | 16,617 |
| 2024-11-18 | Cashman Neil Chief Scientific Officer | Grant or award · Option (right to buy) | +200,000 | 200,000 | ||
| 2023-10-26 | Cashman Neil Chief Scientific Officer | Grant or award · Option (right to buy) | +12,500 | 12,500 | ||
| 2023-08-23 | Cashman Neil Chief Scientific Officer | Grant or award | +10,643 | 113,304 | ||
| 2023-08-23 | Cashman Neil Chief Scientific Officer | Grant or award · Warrants to purchase Common Shares | +10,643 | 10,643 |
Page 1 of 1 · 10 trades